Clinical Trials Using Benralizumab

Clinical trials are research studies that involve people. The clinical trials on this list are studying Benralizumab. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Study of Benralizumab in People with Skin Side Effects Caused by Cancer Therapies

    This phase II trial studies the effect of benralizumab in treating skin side effects caused by cancer therapies. Cancer therapies can cause skin side effects, including rash, itching, or blisters on the skin, which are frequently associated with a type of white blood cell called eosinophils. Eosinophils are part of the immune system; they fight disease, but very high levels of eosinophils can cause inflammation that may damage the skin and cause rash, itching, or blisters. Benralizumab blocks a protein in the blood that helps eosinophils survive. Giving benralizumab may reduce the level of eosinophils in the blood and ultimately reduce the skin side effects. Reducing the skin side effects of the cancer treatment may improve quality of life and allow patients to continue to receive usual cancer treatment.
    Location: Memorial Sloan Kettering Cancer Center, New York, New York